Monoclonal antibody demand in Tennessee and southern states with low COVID-19 vaccination rates led the Biden administration to limit drug supplies.
Source: The Daily News
Tennessee may run low on monoclonal antibodies that treat COVID-19 as feds cap shipments to protect supply
Published in Lascassas
More from LascassasMore posts in Lascassas »
- Tennessee's special session reignited the school safety debate. But what's actually best?
- Can't wait to see fall foliage at its peak? These Nashville-area hikes are the best to see leaves change color
- 2023-2024 Best high schools rankings are out and three Nashville-area schools made the top 100
- Scientists access ORNL's supercomputer from all over: New York, a plane, even Hardee's
- TN special session live updates: As House, Senate end special session, chaos ensues
Be First to Comment